KT-621 has demonstrated dupilumab-like activity and was well tolerated ina wide variety of preclinical models of TH2 diseases KT-621 is…
Poster presentations include new preclinical data demonstrating activity for palazestrant in combination with capivasertib and everolimus, and OP-3136, Olema’s KAT6…
- Maintained Stable Visual Acuity and Anatomical Control Over 9 Months - - Positive Safety Profile with No Ocular or…
Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine MetabolismCALGARY, Alberta, Oct.…
LONDON, Oct. 9, 2024 /PRNewswire/ -- BioCorteX, a leading biotech innovator, today formally announced a breakthrough in the field of Antibody-Drug…
HANGZHOU, China, Oct. 8, 2024 /PRNewswire/ -- Tencent Health and Pfizer China have launched the "Pfizer Smart Healthcare Innovation Ecosystem"…
MENLO PARK, Calif., Oct. 8, 2024 /PRNewswire/ -- Armentum Partners, the leading investment bank focused exclusively on raising non-dilutive and…
HENDERSON, Nev., Oct. 8, 2024 /PRNewswire/ -- Scite, an award-winning platform within the Research Solutions (NASDAQ: RSSS) product family and…
Technological advancements are a primary driver of the Medical Imaging Equipment Services Market, significantly impacting its growth trajectory from 2024…
Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its…